Active substanceBromodihydrochlorophenylbenzodiazepineBromodihydrochlorophenylbenzodiazepine
Similar drugsTo uncover
  • Tranquesipam®
    solution w / m in / in 
    DALHIMFARM, OJSC     Russia
  • Tranquesipam®
    pills inwards 
    DALHIMFARM, OJSC     Russia
  • Fezaneff
    pills inwards 
    AKRIKHIN HFK, JSC     Russia
  • Phenazepam®
    pills inwards 
    VALENTA PHARM, PAO     Russia
  • Phenazepam®
    solution w / m in / in 
    VALENTA PHARM, PAO     Russia
  • Fenzitat®
    pills inwards 
  • Phenorelaxan®
    solution w / m in / in 
  • Phenorelaxan®
    pills inwards 
  • Elzepam®
    solution w / m in / in 
    ELLARA, LTD.     Russia
  • Elzepam®
    pills inwards 
    ELLARA, LTD.     Russia
  • Dosage form: & nbsppills
    Composition:
    For a dosage of 0.5 mg:
    Active ingredient: Bromodihydrochlorophenylbenzodiazepine - 0.5 mg Excipients: lactose (milk sugar) - 69.50 mg, potato starch -28.10 mg, calcium stearate - 1.00 mg, gelatin medical 0.90 mg.
    For a dosage of 1 mg:
    Active ingredient: Bromodihydrochlorophenylbenzodiazepine -1.0 mg Excipients: lactose (milk sugar) - 104.05 mg, potato starch - 42.10 mg, calcium stearate - 1.50 mg, gelatin medical -1.35 mg.

    Description:

    Tablets of white color, flat-cylindrical with a bevel.

    Pharmacotherapeutic group:Anxiolytic agent (tranquilizer).
    ATX: & nbsp

    N.05.B.X   Other anxiolytics

    Pharmacodynamics:Fesipam is a tranquilizer from the benzodiazepine group. Has a pronounced anxiolytic, anticonvulsant, muscle relaxant, sedative and hypnotic effect. Fesipam increases the effect of sleeping pills, narcotic and anticonvulsants, ethyl alcohol. Anxiolytic effect is manifested in the reduction of emotional tension, easing anxiety, fear, anxiety; sedative effect - with regard to the symptoms of neurotic origin: anxiety, fear.
    Pharmacokinetics:

    After ingestion, it is well absorbed from the gastrointestinal tract, TCmax - 1 2 hours Metabolised in the liver. Т1 / 2 - 6-10-18 ч. It is deduced, basically, by kidneys in the form of metabolites.

    Indications:The drug is used for various neurotic, neurotic, psychopathic, psychopathic and other conditions, accompanied by anxiety, fear, increased irritability, tension, emotional lability. With reactive psychoses, hypochondriacal-sensopathic syndrome (including those resistant to the action of other tranquilizers), autonomic dysfunctions and sleep disorders.Prevention of states of fear and emotional stress. As an anticonvulsant, the drug is used to relieve the status epilepticus, serial seizures of various etiologies and for the treatment of hyperkinesia and tics, muscle rigidity. In anesthesiology it is used for premedication as a component of introductory anesthesia.
    Contraindications:

    Severe myasthenia gravis, marked violations of liver and kidney function, pregnancy, poisoning with other tranquilizers, neuroleptics, sleeping pills, drugs, ethyl alcohol.

    Carefully:elderly age
    Dosing and Administration:

    The technique of treatment with fesipam is similar to that of other tranquilizers, it is prescribed internally. A single dose of fesipam is usually 0.0005-0.001 g (0.5-1 mg), and for sleep disorders 0.00025-0,0005 g (0.25-0.5 mg) for 20-30 minutes before bedtime. For the treatment of neurotic, psychopathic, neurosis-like and psychopathic-like conditions, the drug is usually administered orally, the initial dose is 0.0005-0.001 g (0.5-1 mg) 2-3 times a day. After 2-4 days, taking into account the effectiveness and tolerability of the drug, the dose can be increased to 0.004-0.006 g per day (4-6 mg), the morning and daily dose is 0.0005-0.001 g, at night 0.0025 g.With severe agitation, fear, anxiety, treatment starts with a dose of 0.003 g (3 mg) per day, rapidly increasing the dose to obtain a therapeutic effect. In the treatment of epilepsy, the intake dose is 0.002-0.01 g (2-10 mg) per day. For the treatment of alcohol withdrawal, the fesipam is administered orally at a dose of 0.0025-0.005 g (2.5-5 mg) per day. In neurological practice for diseases with increased muscle tone, the drug is prescribed by mouth at 0,002-0,003 (2-3 mg) once or twice a day. The average daily dose of fesipam is 0.0015-0.005 g (1.5-5 mg), it is divided into 2 or 3 doses, usually 0.5-1.0 mg in the morning and in the afternoon and up to 2.5 mg per night. The maximum daily dose of 0.01 g (10 mg). Duration of the course of treatment with an appointment inward to 2 months with parenteral administration up to 3-4 weeks. With the withdrawal of the drug, the dose is reduced gradually. Fesipam is compatible with other drugs (hypnotics, anticonvulsants, etc.), however, it is necessary to take into account the mutual potentiation of their action.

    Side effects:

    Sometimes there is drowsiness, muscle weakness, possibly dizziness, headache, nausea, ataxia, memory impairment and coordination of movements (especially at high doses), drug dependence.The frequency and nature of side effects depend on the individual sensitivity, dose and duration of treatment. With decreasing doses or stopping the use of fesipam, side effects disappear. The drug enhances the effect of alcohol, so the use of alcoholic beverages during treatment with fesipam is not recommended. There may be allergic reactions (skin rash, itching).

    Interaction:

    Strengthens the effect of sleeping pills, narcotic and anticonvulsants, ethanol.

    Special instructions:

    During treatment, one should refrain from engaging in potentially dangerous activities that require concentration of attention and speed of psychomotor reactions, as well as the use of alcoholic beverages.

    Effect on the ability to drive transp. cf. and fur:Fesipam is contraindicated during work by drivers of transport and other persons performing work requiring quick reactions, precise movements and concentration of attention.
    Form release / dosage:

    Tablets of 0.5 mg and 1 mg.

    Packaging:
    For 10 or 25 tablets in a contour mesh package. 2 or 5 contour cell packs of 10 tablets, or 1.2 or 4 out-of-round cell packs of 25 tablets together with instructions for use are placed in a packfrom cardboard.
    Storage conditions:
    In a dry, the dark place at a temperature of no higher than 25 ° C. Keep out of the reach of children.

    Shelf life:

    3 years. Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:LSR-007073/08
    Date of registration:04.09.2008
    The owner of the registration certificate:TATHIMFARMPREPARATY, JSC TATHIMFARMPREPARATY, JSC Russia
    Manufacturer: & nbsp
    Representation: & nbspTATHIMFARM PREPARATIONS OJSC TATHIMFARM PREPARATIONS OJSC Russia
    Information update date: & nbsp10.12.2015
    Illustrated instructions
      Instructions
      Up